Business Wire

Virgin Voyages Begins Construction of First Ship and Starts Taking Deposits

Jaa

Virgin Group Founder Sir Richard Branson and Virgin Voyages President and CEO Tom McAlpin hosted a ‘Ship Tease’, where key details were revealed about what sailors can expect on the first of three ships, coming to the high seas in 2020. Live from Fincantieri’s shipyard in Genoa, Italy, they also celebrated the laying of the keel for the first ship, marking the commencement of construction.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171031006572/en/

Virgin Voyages Ship - Rendering of front of ship. (Photo: Business Wire)

Virgin Voyages Ship - Rendering of front of ship. (Photo: Business Wire)

Sir Richard and Tom McAlpin arrived on stage via a 200-foot crane drop, in true Virgin style. They were joined by Bain Capital Chairman Stephen Pagliuca and Fincantieri’s Alberto Maestrini to weld ceremonial coins into the keel for good luck and smooth sailing.

Richard expressed excitement that construction is now underway. “This is a very big day for Virgin Voyages, as an exciting new holiday option for travelers starts to get ship shape. She will be the most recognizable ship sailing the seven seas, delivering an irresistible sailor experience. We’re also committed to making sure our crew are the happiest at sea and will be proud to sail with us.”

Tom McAlpin shared specifics on the Virgin Voyages design philosophy and experience. “The entire ship will be built with an attention to detail, reflecting the craftsmanship and materiality inspired by super yachts. Designed to feel more intimate and connected to the sea, 86 percent of all cabins will feature a sea terrace and 93 percent an ocean view. Virgin Voyages is creating a sophisticated ship and a transformational experience that offers our sailors a place where rejuvenating day-life meets exciting nightlife and everything in between.”

In a bold and unique move for the industry, McAlpin then gave details that the first ship’s experience will be “Adult By Design” – meaning that sailors must be at least 18 or older to sail. The decision was driven by feedback from future sailors and travel professionals, who are looking for a more elevated and premium experience, with a few Virgin style surprises.

The world also got its first glimpse of the ship’s distinct livery, which will feature a sleek silvery-grey hull, with smoked glass, and of course, distinctive touches of red. The livery was conceptualized by Ben Christie and David Azurdia from the multi-award-winning Magpie Studio in London. RWD from Beaulieu England, who are leaders in super yacht design, created the iconic red Virgin funnel of the vessel.

Virgin Voyages’ first fleet will be known as the “Lady Ships”, a play on the term ‘your ladyship’, giving a nod to Virgin’s British heritage. The spirit of our ship will be represented by a beautiful mermaid design that will adorn the bow. The mermaid is inspired by figureheads on historic vessels and was designed by London-based artist Toby Tinsley, who also designed the beautiful feminine motif on Virgin Galactic.

Consistent with their commitment to have one of the cleanest fleets at sea, Virgin Voyages signed an agreement with Scanship, providers of advanced waste management systems. Together, they will explore the development of potentially game-changing technology that could one day significantly reduce ocean discharge by turning waste into energy.

The final announcement from Virgin Voyages is that it is now “open for business” at virginvoyages.com. Future sailors and travel partners can place a $500 refundable deposit for access to an exclusive pre-sale before Virgin Voyages goes on general sale.

McAlpin wrapped up the ceremony by introducing Grammy Award-winning artist Boy George who then performed as the night’s superstar DJ.

Future sailors and travel partners are invited to check out Virgin Voyages by visiting www.virginvoyages.com or following @virginvoyages on Instagram, Facebook, Twitter or LinkedIn.

About Virgin Voyages

Virgin Voyages is a global travel brand committed to creating the world’s most irresistible holiday. With operations in the US, UK and Europe, Virgin currently has three ships under order with master ship builder Fincantieri. Virgin Voyages first ship will arrive at PortMiami in 2020 for her inaugural sailing season where she will sail to the Caribbean hosting more than 2,700 sailors and 1,150 amazing crew from around the world. Keep watch on virginvoyages.com for more updates.

Contact information

For Virgin Voyages
rbb Communications
Elizabeth Prats, 305-448-5078
Elizabeth.Prats@rbbcommunications.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Record Attendance at Japan Content Showcase 2017!20.11.2017 06:00Tiedote

Japan Content Showcase 2017 was held October 23-26 at Ikebukuro Sunshine City and the Shibuya Excel Hotel Tokyu. A record 19,549 people participated in sales meetings, excluding the TIMM Showcase Live. Other new records this year were 371 exhibiting groups from 27 countries and regions and 1,549 buyers from 48 countries and regions. There was a significant increase in overseas buyers this year, the 1022 foreign registrations representing an increase of more than 10% over last year. The number of non-Japanese Asian buyers increased by 6%, North Americans by 13%, South Americans by 44%, and Europeans by 49%. The number of Middle Eastern buyers doubled, and there were more than five times the number of Russian buyers as last year. French buyers were up 70%, Italians 60%, British 75%, and Germans 50%. Business matching was a new service offered by the organizers this year. Meeti

Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses20.11.2017 03:01Tiedote

Shell and bio-bean announce that together they are helping to power some of London’s buses using a biofuel made partly from waste coffee grounds. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005060/en/ Shell and bio-bean announce that together they are helping to power some of London's buses using a biofuel made partly from waste coffee grounds (Photo: Business Wire) The B20 biofuel contains a 20% bio-component which contains part coffee oil. The biofuel is being added to the London bus fuel supply chain and will help to power some of the buses; without need for modification. Biofuel provides a cleaner, more sustainable energy solution for buses across London’s network by decreasing emissions1. “Our Coffee Logs have already become the fuel of choice for households looking for a

Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®20.11.2017 01:21Tiedote

Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) marketing authorization of ONTRUZANT ® , a biosimilar referencing Herceptin ® (trastuzumab), for the treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer. ONTRUZANT ® is the first trastuzumab biosimilar to receive regulatory approval in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005066/en/ Christopher Hansung Ko, President & CEO of Samsung Bioepis. (Photo: Business Wire) The EC approval of ONTRUZANT ® applies to all 28 European Union (EU) member states and the European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein. ONTRUZANT ® will be commercial

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 19:31Tiedote

Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases19.11.2017 02:00Tiedote

AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 21:20Tiedote

AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme